Prime Medicine, Inc. (PRME) stock
PRMENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$3.82−0.02 (-0.52%)
Close on Nov 18, 2026Market cap $692.86MP/E –Yield –
Prime Medicine price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Prime Medicine's price to sales ratio was 138.2× on Apr 30, 2026, against 76.1× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Apr 30, 2026 | 138.2× | +33.5 |
| 2025 | Dec 31, 2025 | 104.7× | −374.1 |
| 2024 | Dec 31, 2024 | 478.7× | – |
See a number that looks wrong?